2 results
Approved WMOCompleted
The objective of the current study is to assess the effect of speed optimization on clinical and echocardiographic parameters at 3 months follow-up.
Approved WMORecruiting
This entry-into-human (EIH) Phase Ia/Ib study aims to establish the safety,pharmacokinetics, immunogenicity, and pharmacodynamics of RO7284755 (alone or incombination with atezolizumab) and to evaluate its anti-tumor activity.